Search Results

fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old biotech

Plus: must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine

and models of physiological ligand complexes Reviews, GPCRs, and more Sensing host and environmental cues

That money has gone to some 60 biotechs, much of it as early funding."

(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced

Joanne Waldstreicher to its Board of Directors GPCR Therapeutics launches multiple myeloma trial Salipro Biotech organized by LINK-J Jounce takes the cash under amended deal with Gilead on anti-CCR8 antibody InterAx Biotech

Inês Pinheiro and Oliver Hartley from the Orion Biotechnology team on their recent study on Arylsulfatases Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640 Addex to Present at Biotech Conference Isomorphic Labs Announces Strategic Multi-Target Research Collaboration With Novartis Salipro Biotech

Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Therapeutics CEO Pascal Neuville to Discuss Game-Changing GPCR-Targeting Immunotherapies at Sachs Associates' Biotech

I've seen this pattern unfold across biotech, academia, and nonprofits.

Industry News Biotech startup Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech

crucial for sensing extracellular signals, including hormones, neurotransmitters, and environmental cues

with your topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built for biotech GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Industry News InterAx Biotech to Apply its Leading AI and Cell Signalling Technology to Support Target Validation for a Sosei Heptares GPCR Discovery Program Salipro Biotech and DyNAbind Announce Milestone

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

unanswered questions about blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's

Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights Salipro Biotech (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition

prestigious international award – exemplified by the fact that other winners this year are the co-founders of BioNTech

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

In Episode 3 of 3  of our series with Celtarys Research , leaders from academia and biotech unpack what

Translational Impact for Drug Discovery While the Carlsson lab is rooted in academia, its impact extends into biotech

curriculum with your topic suggestions Weekly new releases  to stay ahead of the science Content built for biotech

If you’re in GPCR discovery or biotech R&D, this is a masterclass in turning deep science into scalable

Chris Cargill Wins Executive of the Year at the Citeline Pharma Intelligence Awards Japan 2023 Salipro Biotech

recycling of the receptor with clearance of the ligand from the extracellular space however, the molecular cues

Pairaudeau, CTO of Exscientia discuss transforming drug discovery using their AI-driven platform Salipro Biotech

26RFa by the pyroglutamylated RFamide peptide receptor Industry News NanoImaging Services and Cube Biotech

with your topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built for biotech

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

GPCR scientists, translational pharmacologists, biotech discovery teams, platform company leaders, and

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need